Clinical trials
Terminated Blast Crisis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 3 |
| 2005 | 7 |
| 2006 | 7 |
| 2007 | 4 |
| 2008 | 5 |
| 2009 | 5 |
| 2010 | 6 |
| 2011 | 1 |
| 2012 | 2 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 58 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 8 |
| M.D. Anderson Cancer Center | 6 |
| OHSU Knight Cancer Institute | 5 |
| City of Hope Medical Center | 4 |
| Fred Hutchinson Cancer Center | 4 |
| Masonic Cancer Center, University of Minnesota | 4 |
| Vanderbilt-Ingram Cancer Center | 4 |
| Barbara Ann Karmanos Cancer Institute | 2 |
| H. Lee Moffitt Cancer Center and Research Institute | 2 |
| Northside Hospital, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Blast Crisis | 58 |
| Leukemia, Myeloid, Acute | 42 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 39 |
| Congenital Abnormalities | 37 |
| Leukemia, Myeloid, Accelerated Phase | 36 |
| Leukemia, Myeloid, Chronic-Phase | 33 |
| Leukemia | 32 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 30 |
| Lymphoma, Non-Hodgkin | 28 |
| Myelodysplastic Syndromes | 28 |
Trials
Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.